4.7 Article

Neuronal α-amylase is important for neuronal activity and glycogenolysis and reduces in presence of amyloid beta pathology

期刊

AGING CELL
卷 20, 期 8, 页码 -

出版社

WILEY
DOI: 10.1111/acel.13433

关键词

alpha-amylases; Alzheimer's disease; amyloid beta-peptides; calcium imaging; glycogen; induced pluripotent stem cells; tendamistat

资金

  1. Gamla tjanarinnor [2020-00993]
  2. Royal Physiographic Society of Lund
  3. Novo Nordisk Foundation [GliAD-NNF18OC0052369]
  4. Innovation Fund Denmark [4108-00008B]
  5. Crafoord Foundation [2020-0549]
  6. Dementia Foundation
  7. Swedish Research Council [2018-02564]
  8. Swedish Research Council [2018-02564] Funding Source: Swedish Research Council

向作者/读者索取更多资源

Recent studies suggest that neuronal alpha-amylase plays a crucial role in memory formation by degrading glycogen. Alpha-amylase deficiency in Alzheimer's disease patients may contribute to disrupted memory formation. The loss of alpha-amylase, induced by Aβ pathology, may be an underlying factor in impaired memory formation seen in AD patients.
Recent studies indicate a crucial role for neuronal glycogen storage and degradation in memory formation. We have previously identified alpha-amylase (alpha-amylase), a glycogen degradation enzyme, located within synaptic-like structures in CA1 pyramidal neurons and shown that individuals with a high copy number variation of alpha-amylase perform better on the episodic memory test. We reported that neuronal alpha-amylase was absent in patients with Alzheimer's disease (AD) and that this loss corresponded to increased AD pathology. In the current study, we verified these findings in a larger patient cohort and determined a similar reduction in alpha-amylase immunoreactivity in the molecular layer of hippocampus in AD patients. Next, we demonstrated reduced alpha-amylase concentrations in oligomer amyloid beta 42 (A beta(42)) stimulated SH-SY5Y cells and neurons derived from human-induced pluripotent stem cells (hiPSC) with PSEN1 mutation. Reduction of alpha-amylase production and activity, induced by siRNA and alpha-amylase inhibitor Tendamistat, respectively, was further shown to enhance glycogen load in SH-SY5Y cells. Both oligomer A beta(42) stimulated SH-SY5Y cells and hiPSC neurons with PSEN1 mutation showed, however, reduced load of glycogen. Finally, we demonstrate the presence of alpha-amylase within synapses of isolated primary neurons and show that inhibition of alpha-amylase activity with Tendamistat alters neuronal activity measured by calcium imaging. In view of these findings, we hypothesize that alpha-amylase has a glycogen degrading function within synapses, potentially important in memory formation. Hence, a loss of alpha-amylase, which can be induced by A beta pathology, may in part underlie the disrupted memory formation seen in AD patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据